SSC CHSL 2020: Staff Selection Commission has announced the tentative list of vacancies for the Combined Higher Secondary Level (CHSL) examination 2020. There are a total of 4726 vacancies this year, including 158 vacancies for LDC/JSA/JPA, 3181 for PA/SA, and seven for DEO posts.
In the year 2019, the number of vacancies for the CHSL exam was 4893 while in 2018, it was 5789.
Also read: SAIL Recruitment 2021: Apply for 39 vacancies
Imp. date
The online application process for SSC CHSL 2020 is going on. The last date to apply for the posts is December 15. Aspirants can apply online on the official website. SSC CHSL 2020 tier-1 exam will be held from April 12 to 27, 2021.
Check SSC CHSL 2020 vacancies here
SSC CHSL 2020: PAY SCALE
Lower Division Clerk (LDC)/Junior Secretariat Assistant (JSA): Pay Level-2 (Rs. 19,900-63,200).
Postal Assistant (PA)/Sorting Assistant (SA): Pay Level-4 (Rs. 25,500-81,100).
Data Entry Operator (DEO): Pay Level-4(Rs. 25,500-81,100) and Level-5(Rs. 29,200-92,300).
Data Entry Operator, Grade ‘A’: Pay Level-4(Rs. 25,500-81,100).
ELIGIBILITY:
For LDC/ JSA, PA/ SA, DEO (except DEOs in C&AG): Candidates must have passed the 12th Standard or equivalent examination from a recognized Board or University.
For Data Entry Operator (DEO Grade ‘A’) in the Office of Comptroller and Auditor General of India (C&AG): 12th Standard pass in Science stream with Mathematics as a subject from a recognized Board or equivalent.
How to apply
Aspirants can apply online at ssc.nic.in.(click here)
Mean-while, India recorded 32,080 new COVID-19 cases in the last 24 hours, taking the total number of active coronavirus cases in the country to 3,78,909, said the Union Ministry of Health and Family Welfare on Wednesday. With 36.635 new recoveries, the number of overall recovered COVID-19 patients stands at 92,15,581, pushing the recovery rate to 94.66 percent.
The overall COVID-19 cases reached 97,35,850, including 3,78,909 active cases and 92,15,581 recoveries. With 402 new deaths, the casualties mounted to 1,41,360
Oxford University and AstraZeneca on Tuesday became the first Covid-19 vaccine makers to publish final-stage clinical trial data in a scientific journal, clearing a key hurdle in the global race to produce safe and effective drugs for the coronavirus.